Spero Therapeutics, Inc.

SPRO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 25 employees
175
SEC Filings
$1.12
Close 2026-10-19
25
Employees

Business Summary

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need. Founded in 2013, its primary product candidate is tebipenem HBr (tebipenem pivoxil hydrobromide), a potential first oral carbapenem antibiotic for treating complicated urinary tract infections (cUTIs) in adults. The company has an exclusive license agreement with GSK for development, manufacture, and commercialization of tebipenem HBr.

Latest Stock Quote

SPRO 2026-10-19 $1.12 O:$1.09 H:$1.13 L:$1.09 Vol:0.2M VWAP:$1.1089
origin leaf: null

Next Earnings

expected 2027-02-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126192EDGAR100K words
2025-03-272024-12-310000950170-25-046125EDGAR101K words
2024-03-132023-12-310000950170-24-030767EDGAR116K words
2023-03-302022-12-310000950170-23-010921EDGAR115K words
2022-03-312021-12-310000950170-22-005194EDGAR123K words
2021-03-112020-12-310001564590-21-012514EDGAR101K words
2020-03-162019-12-310001564590-20-010998EDGAR110K words
2019-03-142018-12-310001564590-19-007805EDGAR105K words
2018-04-022017-12-310001564590-18-007402EDGAR99K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001193125-26-458593EDGAR71K words
2026-08-122026-06-300001193125-26-346795EDGAR69K words
2025-11-132025-09-300001193125-25-280174EDGAR68K words
2025-08-122025-06-300000950170-25-107388EDGAR68K words
2025-05-132025-03-310000950170-25-070380EDGAR62K words
2024-11-142024-09-300000950170-24-127016EDGAR60K words
2024-08-052024-06-300000950170-24-090782EDGAR58K words
2024-05-152024-03-310000950170-24-060400EDGAR54K words
2023-11-132023-09-300000950170-23-062897EDGAR63K words
2023-08-102023-06-300000950170-23-041314EDGAR62K words
2023-05-112023-03-310000950170-23-021187EDGAR57K words
2022-11-142022-09-300000950170-22-024971EDGAR67K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-120001193125-26-458637EDGAR1K words
2026-11-100001193125-26-455789EDGAR1K words
2026-10-270001193125-26-434452EDGAR1K words
2026-08-280001193125-26-374788EDGAR1K words
2026-08-120001193125-26-346855EDGAR2K words
2026-07-140001193125-26-302473EDGAR3K words
2026-03-260001193125-26-126244EDGAR3K words
2026-01-300001193125-26-032004EDGAR1K words
2025-12-190001193125-25-325821EDGAR1K words
2025-11-130001193125-25-280518EDGAR2K words

175 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

complicated-urinary-tract-infections-(cuti) antibiotic-resistant-bacterial-infections rare-diseases hospital-acquired-and-ventilator-associated-bacterial-pneumonia-(habp/vabp) nontuberculous-mycobacterial-pulmonary-disease-(ntm-pd)

Company Identity

CIK0001701108
TickerSPRO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.sperotherapeutics.com
Listed2017-11-02

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 424f0bb435bf3b172cddee0223eb6b3d90d764ff087922cb8af66bf0e53141bd
parent: 6081be0def79b8f97b915b93fa6a40fd9a1d40311ec754d5ac6eb628c5e81f76
content hash: 5d77eb37daf5929a7bad71b207191d9cd03f5367e2ce9426a9e7f3e42d1bee17
signed: 2026-11-16T19:04:53.927Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SPRO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SPRO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SPRO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.